Published in Gene Therapy Weekly, October 5th, 2000
"Infection by certain subsets of HPV, most notably HPV types 16 and 18, has been implicated as the principal etiologic agents of cervical cancer," reported Dariusz W. Kowalczyk and colleagues from the Wistar Institute, Pennsylvania, and the Polish Academy of Sciences, Poland. "Thus development of effective vaccines to prevent or treat HPV infection could have a major impact on tumors caused by these viruses."
Kowalczyk et al. presented data from their study at the 14th...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.